logo-loader
RNS
Judges Scientific PLC

Judges ScientificPLC - Executive Director and Board Appointment

RNS Number : 3862C
Judges Scientific PLC
02 September 2024
 

Press Release

2 September 2024

 

Judges Scientific plc

 

("Judges Scientific" or the "Company")

 

Executive Director and Board Appointment

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces the appointment of Dr Ian Wilcock to the Board as Group Commercial Director, with immediate effect. Ian will work alongside Mark Lavelle and Dr Tim Prestidge in supporting the growth and development of our businesses.

 

With 30 years of experience in senior positions at FTSE 250 and Fortune 500 global technology and scientific instrument businesses, Ian joins Judges with a strong track record in leadership, technology commercialisation and innovation.

 

Ian started his career at Renishaw plc, before twice forming part of the leadership teams of investor-backed SMEs which were acquired by corporates (Footfall by Experian in 2006, and Irisys by Danaher in 2012). Following four years with Danaher, Ian most recently spent eight years as a member of the Management Board of Oxford Instruments plc, leading significant organic and inorganic growth and establishing its Materials Analysis Division.

 

Teams led by Ian have won several awards, including 3 Queen's Awards for Enterprise in the Innovation category, and more recently a King's Award in the Innovation category.

 

Ian holds degrees in Chemical Physics from the University of Edinburgh, an MBA from the University of Bath, and conducted post-doctoral research in Gerhard Ertl's Nobel Prize-winning group at the Fritz Haber Institut, Berlin.

 

Alex Hambro, Chairman of Judges, said: "We are delighted to welcome Ian to the Judges board, who brings with him a wealth of valuable experience. We look forward to benefitting from his expertise as the Group continues to execute its buy and build growth strategy."

 

For further information please contact: 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 


Panmure Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 20 7597 4000


Alma (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewett

Joe Pederzolli

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com



 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group now consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

Regulatory Information

In accordance with Schedule 2(g) of the AIM Rules, Ian Christopher Wilcock, aged 57, holds or has held in the past 5 years the following directorships and trusteeships:

 

Current directorships/trusteeships

Oxford Instruments Italia s.r.l

 

Past directorships/trusteeships

Oxford Instruments Industrial Products Limited

Oxford Instruments Nanotechnology Tools Limited

Oxford Instruments Nordiska AB

Oxford Instruments SAS

Oxford Instruments Technology (Shanghai) Co. Limited

WITec Wissenschaftliche Instrumente und Technologie GmbH

 

Ian Christopher Wilcock has confirmed that save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPMMATMTTJBII
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Director/PDMR Shareholding

3 days, 5 hours ago

Holding(s) in Company

3 days, 10 hours ago

Director/PDMR Shareholding

1 week, 2 days ago

Holding(s) in Company

on 10/20/2026

Board change

on 09/23/2026

Interim Results

on 09/23/2026

4 min read